Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
107.27
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Best Stocks for 2022: Why AbbVie Looks Like High Dividend Growth Stock
December 30, 2021
A solid year and an excellent third-quarter report from AbbVie has ABBV stock look like it is one of the best stocks to buy for 2022.
Via
InvestorPlace
CES 2022: Electric Vehicles, Digital Health, Metaverse In Focus
December 30, 2021
CES will spotlight EVs, digital health, the metaverse and other hot technologies, Jan. 5-8.
Via
Investor's Business Daily
7 Dividend Increases Expected In January 2022
December 30, 2021
How many dividend increases are you going to receive this month? How many stocks on this list do you own? Are you ready to crush it in 2022?
Via
Talk Markets
Price Over Earnings Overview: Abbott Laboratories
December 29, 2021
In the current session, Abbott Laboratories Inc. (NYSE:ABT) is trading at $140.53, after a 0.1% increase. Over the past month, the stock increased by 10.83%, and in...
Via
Benzinga
5 Stocks Insiders Are Selling
December 29, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
Expert Ratings For Abbott Laboratories
December 10, 2021
Within the last quarter, Abbott Laboratories (NYSE:ABT) has observed the follo...
Via
Benzinga
Could This Company's Device Be What the Cardiology Market Has Been Yearning For? Company Touts it as a Lifesaver
December 28, 2021
Photo by Towfiqu Barbhuiya on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Watch for Continued Gains in Shares of Abbott Laboratories
December 27, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded at a new 12-month high today of $142.60. This new high was reached on below-average trading volume as 814,000 shares traded hands...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
December 21, 2021
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to...
Via
Benzinga
Abbott Laboratories: Debt Overview
December 21, 2021
Shares of Abbott Laboratories (NYSE:ABT) moved higher by 8.53% in the past three months. Before we understand the importance of debt, let us look at how much debt Abbott...
Via
Benzinga
This Cardiac Device Could Possibly Be the Game Changer That Saves Millions of Lives
December 21, 2021
Photo by Jesse Orrico on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Abbott Laboratories: The Winning Streak Continues
December 17, 2021
Abbott Laboratories (NYSE: ABT) traded at a new 12-month high today of $139.11. Approximately 4 million shares have changed hands today, as compared to an average 30-day volume of...
Via
Benzinga
$1000 Invested In This Stock Over The Last 5 Years, Would Be Worth This Much
December 16, 2021
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 13.08% on an annualized basis. Buying $1,000.00 In ABT: 5 years ago, an investor could have...
Via
Benzinga
Johnson & Johnson: What Should Investors Do Following The Consumer Health Spinoff?
December 15, 2021
A sizeable change in direction for one of the country’s oldest companies was probably a shock to many shareholders.
Via
Talk Markets
3 Coronavirus Stocks To Buy In December
December 11, 2021
Moderna is the leading company in the development of messenger RNA-based medicines and vaccines to treat infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune...
Via
Talk Markets
Exposures
COVID-19
3 Healthcare Stocks for Long-Term Dividend Growth
December 10, 2021
Dividend investors face a variety of choices. We like healthcare stocks for many reasons, such as long-term earnings growth.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
December 09, 2021
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 12.02% on an annualized basis. Buying $100.00 In ABT: 5 years ago, an investor could have...
Via
Benzinga
This Biotech CEO Is Trying To Cure His Son's Rare Disease
December 09, 2021
Few questions stump Tim Walbert. But the Horizon Therapeutics CEO is still working to answer one of them from his son.
Via
Investor's Business Daily
Watch for Continued Gains in Shares of Abbott Laboratories
December 07, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an...
Via
Benzinga
How Did Healthcare Stocks Perform Over This Volatile Month?
December 06, 2021
It’s been a rough month for small-cap biotech stocks amidst a general correction in the market which brought general indices down about 10%.
Via
Talk Markets
Watch for Continued Gains in Shares of Abbott Laboratories
December 06, 2021
Shares of Abbott Laboratories (NYSE: ABT) traded today at $132.41, eclipsing its 12-month high. Approximately 1.4 million shares have changed hands today, as compared to an...
Via
Benzinga
7 Stocks to Buy to Give Your Portfolio a Booster Shot
December 06, 2021
With the new strain already reported in the U.S., it’s time to consider some adjustments to your portfolio.
Via
InvestorPlace
Exposures
COVID-19
Abbott Labs Stock Climbs Into Top-Performers Group Amid Continued double- and triple-digit Profit, Sales Growth
December 06, 2021
A Relative Strength Rating upgrade for Abbott Laboratories shows improving technical performance.
Via
Investor's Business Daily
Even Good Penny Stocks Like Senseonics Aren’t Always Profitable
December 03, 2021
Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.
Via
InvestorPlace
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
President Biden announced that private health insurance plans would soon reimburse people who buy over-the-counter (OTC), at-home rapid tests for COVID-19. What Happened...
Via
Benzinga
Exposures
COVID-19
Notable Abbott Laboratories Insider Trades $5.5M In Company Stock
November 18, 2021
Gregory A Ahlberg, Insider at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on November 15, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Danaher Stock Shows Renewed Strength, Earning Key Rating Hike Amid Rising Profits, Sales
November 18, 2021
A Relative Strength Rating upgrade for Danaher shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Better Buy: DexCom or Abbott Labs?
November 17, 2021
Abbott's the heavyweight, and DexCom is the formidable challenger.
Via
The Motley Fool
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.